Tag: David Amess

The below Parliamentary question was asked by David Amess on 2016-07-20.

To ask the Secretary of State for Health, with reference to Written Statement HCW588 on Infected Blood Payment Scheme, whether entitlement to the new annual payments for people infected with hepatitis C via infected blood and blood products will continue for the lifetime of the individual even if they are successfully treated for their hepatitis C.

Nicola Blackwood

The reformed scheme will provide a payment to all those with hepatitis C, even if they have been treated, for the current spending review period. A review of the scheme will take place towards the end of this spending review period.

All those who are currently bereaved partners/spouses and all those who will be bereaved partner/spouses in future will receive a £10,000 lump sum payment and will have continued access to discretionary support. Discretionary support will continue to be available to the bereaved, as well as to infected individuals.

All infected individuals who are registered with Skipton as having hepatitis C stage 1 (nearly 2,500 people) will be eligible for the new stage 1 annual payment.

The below Parliamentary question was asked by David Amess on 2015-10-22.

To ask the Secretary of State for Transport, what assessment the Government has made of the financial effect on consumers of the requirement for drivers to be insured at all times under the Road Safety Act 2006.

Andrew Jones

Since the introduction of the Continuous Insurance Enforcement (CIE) scheme, the level of uninsured driving has been reduced from 1.4 million vehicles at the end of 2010 to 1.0 million at the end of 2014, a 29% reduction. CIE has promoted positive changes in vehicle keeper behaviour and contributes significantly to making our roads safer and in helping keep down insurance premiums for the honest motorist.

The below Parliamentary question was asked by David Amess on 2015-10-26.

To ask the Secretary of State for Transport, what assessment he has made of the implications for his policies of the recommendations of the Maritime Growth Study, published on 7 September 2015, on reforms to the UK ship register.

Mr Robert Goodwill

The Government will respond formally to the Maritime Growth Study by the end of 2015, but is taking immediate action in response to some recommendations. This includes the establishment of a Ministerial Working Group for Maritime Growth and taking steps to support the improved operation of the Maritime & Coastguard Agency (MCA) such as appointing a commercial director to lead the UK Ship Register separately from the Agency’s regulatory functions and a business case exploring the costs and benefits of options for more significant reform of the MCA.

The below Parliamentary question was asked by David Amess on 2015-10-22.

To ask Mr Chancellor of the Exchequer, what assessment the Government has made of the effect on consumers of the practice of insurers in signing customers up to automatic policy renewals without the option to opt-out; and if he will make a statement.

Harriett Baldwin

This is a matter for the Financial Conduct Authority (FCA), who are operationally independent from Government.

The question has been passed on to the FCA. The FCA will reply directly to the honourable member by letter. A copy of the letter will be placed in the Library of the House.

The below Parliamentary question was asked by David Amess on 2015-10-22.

To ask Mr Chancellor of the Exchequer, what assessment he has made of the effect on competition in the private motor insurance market of automatic policy renewals; and if he will make a statement.

Harriett Baldwin

This is a matter for the Financial Conduct Authority (FCA), who are operationally independent from Government.

The question has been passed on to the FCA. The FCA will reply directly to the honourable member by letter. A copy of the letter will be placed in the Library of the House.

The below Parliamentary question was asked by David Amess on 2015-10-22.

To ask Mr Chancellor of the Exchequer, what assessment the Government has made of the effect on consumers of the practice of insurers in not giving details of no claims bonuses to customers in their renewal notice; and if he will make a statement.

Harriett Baldwin

This is a matter for the Financial Conduct Authority (FCA), who are operationally independent from Government.

The question has been passed on to the FCA. The FCA will reply directly to the honourable member by letter. A copy of the letter will be placed in the Library of the House.

The below Parliamentary question was asked by David Amess on 2015-10-22.

To ask Mr Chancellor of the Exchequer, what assessment he has made of the effect on consumers of the practice of insurers in automatically signing-up customers to annual policy renewals without their explicit consent; and if he will make a statement.

Harriett Baldwin

This is a matter for the Financial Conduct Authority (FCA), who are operationally independent from Government.

The question has been passed on to the FCA. The FCA will reply directly to the honourable member by letter. A copy of the letter will be placed in the Library of the House.

The below Parliamentary question was asked by David Amess on 2015-10-09.

To ask the Secretary of State for Health, whether the mechanisms used by NHS England to collect information on patient experience include metrics on (a) shared decision-making and (b) self-management.

Ben Gummer

NHS England collects patient experience information through a programme of national patient experience surveys, which depending on the survey, are managed by either NHS England or the Care Quality Commission.

National surveys containing questions that can be used to assess the extent to which patients feel they are being involved in shared decision-making include: the National Survey of Bereaved People, the Cancer Patient Experience Survey, the GP Patient Survey, and surveys in accident and emergency, maternity, mental health and inpatient settings.

Questions asking patients about their view and support to self-manage are included in both the Cancer Patient Experience Survey and the GP Patient Survey and in addition, NHS England is testing the use of a Patient Activation Measure within the National Health Service, to support self-management and person centred care.

The below Parliamentary question was asked by David Amess on 2015-10-09.

To ask the Secretary of State for Health, how many stakeholders responded to the consultation on the Call to Action on improving eye health and provision of NHS eye health services.

Alistair Burt

NHS England received 330 responses to the Call to Action on improving eye health and provision of NHS eye health services.

The total identifiable spend by NHS England on the Call to Action was £34,184. This consisted of £25,950 for engagement events and £8,234 for the compilation of responses. Figures provided are exclusive of VAT. No consultants were employed.

There are no current plans for NHS England to publish a report on the Call to Action, however, the findings have been discussed with commissioners and stakeholders. Work is underway to develop local and national responses to the findings as part of NHS England business plan for 2016/17.

The below Parliamentary question was asked by David Amess on 2015-10-09.

To ask the Secretary of State for Health, how much was spent (a) in total and (b) on consultancy and engagement events for the Call to Action on improving eye health and provision of NHS eye health services.

Alistair Burt

NHS England received 330 responses to the Call to Action on improving eye health and provision of NHS eye health services.

The total identifiable spend by NHS England on the Call to Action was £34,184. This consisted of £25,950 for engagement events and £8,234 for the compilation of responses. Figures provided are exclusive of VAT. No consultants were employed.

There are no current plans for NHS England to publish a report on the Call to Action, however, the findings have been discussed with commissioners and stakeholders. Work is underway to develop local and national responses to the findings as part of NHS England business plan for 2016/17.